- Home
- RMNI vs ORGO Comparison
RMNI vs ORGO Comparison
Compare RMNI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMNI | ORGO |
|---|---|---|
| Founded | 2005 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.1M | 348.6M |
| IPO Year | 2015 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RMNI | ORGO |
|---|---|---|
| Price | $3.98 | $2.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $5.00 | ★ $8.50 |
| AVG Volume (30 Days) | 305.1K | ★ 1.8M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 197.50 | ★ 1600.00 |
| EPS | 0.01 | ★ 0.15 |
| Revenue | $431,496,000.00 | ★ $564,169,000.00 |
| Revenue This Year | $6.02 | N/A |
| Revenue Next Year | $5.50 | $26.27 |
| P/E Ratio | ★ $8.74 | $15.57 |
| Revenue Growth | 5.33 | ★ 17.04 |
| 52 Week Low | $2.87 | $2.21 |
| 52 Week High | $5.38 | $7.08 |
Technical Indicators
Market Signals| Indicator | RMNI | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 69.61 | 57.30 |
| Support Level | $3.91 | $2.26 |
| Resistance Level | $4.15 | $4.12 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 85.63 | 88.61 |
Price Performance
Historical ComparisonAbout RMNI Rimini Street Inc. (DE)
Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.